The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.




AMA submission on TGA proposals ​for naming biological medicines

12 Oct 2017

The AMA recommends the TGA maintains the status quo for differentiating between biological and biosimilar medicines for monitoring and reporting purposes at this stage, until international regulators have implemented their own systems and Australia can learn from their experience.

Published: 12 Oct 2017